Delayed-Release Oral Mesalamine 4.8 g/day (800-mg Tablet) Is Effective for Patients With Moderately Active Ulcerative Colitis
Autor: | Sandborn, William J., Regula, Jaroslaw, Feagan, Brian G., Belousova, Elena, Jojic, Njegica, Lukas, Milan, Yacyshyn, Bruce, Krzeski, Piotr, Yeh, Chyon–Hwa, Messer, Christi A., Hanauer, Stephen B. |
---|---|
Zdroj: | In Gastroenterology December 2009 137(6):1934-1943 |
Databáze: | ScienceDirect |
Externí odkaz: |